Timken Company <TKR.N>: BofA Global Research raises price objective to $135.00 from $129.00
TKR•Related News
Brazil's economy grows 0.5% in second quarter
EWZ•
SAB Biotherapeutics CEO Samuel Reich joins Citi Biopharma Back to School Conference fireside chat
SABS•
Xerox partners with Flint Group Digital Xeikon to expand production print portfolio
XRX•
RenX takes delivery of Microtec turbo mill at Florida organics facility
RENX•
Welltower Inc. <WELL.N>: Morgan Stanley Raises Target Price to $251 From $215
WELL•